Objective Methotrexate (MTX) is an economic and effective medicine treatment for psoriasis.
Extracellular vesicle (EV) miRNA biomarkers related to its efficiency have been identified in …

Psoriasis vulgaris is a common chronic and recurrent inflammatory skin disease. In clinical
practice, acitretin is the first-line treatment drug for psoriasis vulgaris. MicroRNAs (miRNAs) …

Background Psoriasis is a chronic inflammatory disorder characterized by pathogenic
hyperproliferation of keratinocytes and immune dysregulation. Currently, objective …

BACKGROUND Specific profile of microRNAs (miRNAs, miR) expressed in psoriasis has
been identified in the past few years, while the studies on roles and molecular mechanisms …

Objective: Systematic tracking of microRNA (miRNA) targets remains a challenge. In our
work, we aimed to use TargetScore to investigate the potential targets of miRNA203 and …

Psoriasis is a chronic skin disease that affects a significant number of patients and can
severely impair quality of life. Although the diagnosis is normally clinical, paraclinical …

Background Rheumatoid arthritis (RA) is an autoimmune disorder characterized by
inflammation-induced joint damage, which can cause lasting disability. Therefore, early …

Psoriasis is a chronic skin disease affecting 1% to 3% of the world population. Psoriasis
vulgaris (PV) is the most common form of psoriasis. PV patients suffer from inflamed, pruritic …

This study aimed to evaluate the role of microRNAs (miRNA) as biomarkers of treatment
response in rheumatoid arthritis (RA) patients through a systematic review of the literature …

Psoriasis is an auto-inflammatory skin disease characterized by abnormal activation of
epidermal keratinocytes, aberrant neovascularization, and dysregulation of immune cells …